Last reviewed · How we verify

NCT04943471

Personality Traits in Patients Seeking a Consultation for Treatment for Floaters

Completed Last updated 31 August 2022
What this trial tests

trial testing Big Five Questionnaire, Patient health questionnaire-9 and generalised anxiety disorder -7 questionnaire in Myodesopia in 153 participants. Completed in 3 August 2022.

Timeline
15 December 2021
Primary endpoint
3 August 2022
3 August 2022

Quick facts

Lead sponsorManchester University NHS Foundation Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment153
Start date15 December 2021
Primary completion3 August 2022
Estimated completion3 August 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Manchester University NHS Foundation Trust

Who can join

18 and older, any sex, with Myodesopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess if certain personality traits are move prevalent in patients seeking consultation for treatment of floaters, despite good visual acuity and no other ocular pathology compared to the normal population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Manchester University NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04943471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing